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A B S T R A C T
Laminitis, one of the most debilitating conditions of all equids, is now known to be the result of several
systemic disease entities. This ﬁnding, together with other recent developments in the ﬁeld of laminitis
research, have provoked a rethink of our clinical and research strategies for this condition. First, laminitis
is now considered to be a clinical syndrome associated with systemic disease (endocrine disease, sepsis
or systemic inﬂammatory response syndrome, SIRS) or altered weight bearing rather than being a
discrete disease entity. Next, laminitis associated with endocrine disease (endocrinopathic laminitis) is
now believed to be the predominant form in animals presenting (primarily) for lameness. Third, the
designation of laminitis as a primary and severe basement membrane pathology now requires revision.
Instead, current data now proposes a variable subclinical phase associated with gross changes in the hoof
capsule, with stretching and elongation of the lamellar cells an early and key event in the
pathophysiology. These ﬁndings have fuelled new mechanistic hypotheses and research directions
that will be discussed, together with their implications for future clinical management.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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Laminitis has long been recognised as a painful condition of the
hoof that causes lameness in horses (Heymering, 2010), with
modern studies of the condition that can be traced back to a
doctoral thesis published in the late forties (Obel, 1948). Laminitis
can have debilitating long-term effects as a recurrent or chronic
condition and, at worst, necessitates euthanasia of an animal in
considerable pain (Hunt, 1993). At clinical presentation, we
typically see lameness involving one or multiple hooves, stiffness,
weight shifting, a typical ‘saw horse’ stance and reluctance to
move, increased digital arterial pulses and sensitivity to hoof tester
pressure applied at the toe of the affected digit(s) (Dyson, 2011).
Many horses also present with gross hoof wall alterations that
include divergent rings, increased cap horn or a wider/separated
white line, and ﬂat or convex soles (Pollitt, 2004; Collins et al.,
2010; Karikoski et al., 2015) (Fig. 1).
Historically, ‘classical laminitis’ was linked with severe con-
ditions associated with sepsis or systemic inﬂammatory response
syndrome (SIRS), with deliberate starch overload or with the
induction of metritis used to create experimental models (Obel,
1948). Conversely, supporting limb laminitis can result from any* Corresponding author.
E-mail address: cmcgowan@liverpool.ac.uk (C.M. McGowan).
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bearing (Baxter and Morrison, 2009; van Eps et al., 2010; Virgin
et al., 2011). The 1980s saw publication of the ﬁrst hypotheses to
link endocrine disease and laminitis, termed ‘endocrinopathic
laminitis’ (Coffman and Colles, 1983; Jeffcott et al., 1986), with
resistance to insulin or its abnormal regulation being a common
association, especially in pony breeds.
Until relatively recently, research continued to focus on
laminitis provoked by inﬂammation. It took a ground breaking
study of a single herd of mixed Welsh and Dartmoor breed ponies,
some with previous laminitis, to reveal the differences between
these and ‘laminitis-naive animals’ (Treiber et al., 2006). Critically,
these differences included higher basal insulin concentrations,
plasma triglycerides, and body condition scores (Treiber et al.,
2006). The ﬁve-fold increase in basal insulin concentration that
accompanied the redevelopment of laminitis in a subset of ponies
(n = 13) grazed on lush pasture was a particularly provocative
ﬁnding (Treiber et al., 2006). Contemporaneously, an independent
group successfully developed an experimental model of hyper-
insulinaemic laminitis (Asplin et al., 2007) based on clinical
observations made with horses with pituitary pars intermedia
dysfunction (PPID) or other endocrine diseases (now termed
equine metabolic syndrome, EMS). The high frequency of horses
demonstrating (marked) hyperinsulinaemia when affected with
endocrine disease was already known, together with the poorer
prognosis (survival over 2 years) that accompanies presentationle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. (a) Divergent rings on the outer hoof wall of a pony without current lameness. (b) Solar hoof surface of a pony showing a convex or ‘dropped’ sole and a widened white
line.
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increased levels of basal serum insulin (<62 mIU/mL) (McGowan
et al., 2004).
More recently, studies of spontaneous endocrinopathic lamini-
tis and hyperinsulinaemic models have markedly changed our
perception of laminitis, which now warrants a re-evaluation of its
clinical management and future research directions.
Paradigm shift 1: Laminitis is a clinical syndrome
Laminitis is now thought to be a clinical syndrome (rather than
a discrete disease) that results from several systemic disease
entities or, less frequently (as above), in the supporting limb of a
lame horse (Baxter and Morrison, 2009; van Eps et al., 2010; Virgin
et al., 2011; Wylie et al., 2015). Since 1948, laminitis had been
considered to be a disease entity, albeit with obscure cause(s) that
could be studied in the context of SIRS induced with starch or
oligofructose, collectively termed carbohydrate overload models
(Obel, 1948; Garner et al., 1975; Galey et al., 1991; van Eps and
Pollitt, 2009). Despite recognition of the association between
endocrine disease and laminitis, this connection was largely
ignored. It was not until ‘endocrinopathic’ laminitis was unequiv-
ocally induced in a hyperinsulinaemia model that it became clear
that laminitis could be provoked by multiple stimuli. Speciﬁcally,
laminitis was induced in 5/5 previously healthy, young, and lean
ponies following exposure to prolonged hyperinsulinaemia while
maintaining euglycaemia (Asplin et al., 2007). Repetition in normal
Standardbred horses yielded similar results (de Laat et al., 2010),
while mild hyperglycaemia (mean  standard error, SE, glucoseTable 1
Comparison of key signalment and clinical ﬁndings in horses (n = 73) developing laminiti
with lameness due to laminitis as the primary problem (Karikoski et al., 2011).
Factor Hospitalised horses (Parsons 
Mean age 5.8 years 
Breeds 82.5% light breeds (Thoroughbred, S
Quarterhorse and Arabian)
Endotoxaemia (SIRS)a Present, and signiﬁcantly associated
development of laminitis on multiva
(odds ratio 5, 95% conﬁdence interv
Other indicators of illness Yes, on univariable analysis 
Phenotypic indicators of equine metabolic
syndrome/diagnosis of pituitary pars
intermedia dysfunction (PPID)
Not recorded 
Hyperinsulinaemia Not recorded 
Evidence of previous laminitis Not recorded 
a Endotoxaemia, now termed systemic inﬂammatory response syndrome (SIRS), was d
hyperaemic perialveolar gingiva, and supportive laboratory ﬁndings, such as neutropae
b Clinical evidence of SIRS was an exclusion criterion for the study (Karikoski et al., 10.7  0.78 mmol/L) and endogenous hyperinsulinaemia (mean 
SE insulin 208  26.1 mIU/mL) induced lamellar lesions, but not a
painful condition (de Laat et al., 2012).
This simple but important paradigm shift had several impli-
cations, the main one being that an accurate diagnosis of the
associated systemic disease (or abnormal weight bearing) would
be pivotal for laminitis management, prognosis and the prevention
of recurrence. Additionally, the recognition of divergent causes of
laminitis and associated risk factors (Table 1) could now improve
the design of research studies that had, hitherto, proven to be
inconclusive (Wylie et al., 2012).
Paradigm shift 2: Endocrinopathic laminitis predominates in
animals presenting for lameness
Endocrinopathic laminitis is now recognised as the most
common form of naturally occurring laminitis in horses and
ponies presenting primarily with lameness in developed countries,
including the USA and Europe (Donaldson et al., 2004; Karikoski
et al., 2011). An earlier misconception that laminitis was
predominantly associated with sepsis or SIRS arose from its
prevalence in equids treated at veterinary referral hospitals, where
laminitis research is concentrated (Parsons et al., 2007). This
misperception was highlighted by a large epidemiological study in
the USA (USDA, 2000), which showed that grain overload, retained
placenta, colic or diarrhoea accounted for only 12% of owner-
reported cases of laminitis; the remainder were associated with
dietary problems or obesity, or were of unknown cause. Subse-
quent, more convincing studies from the USA and Europes during hospitalisation (Parsons et al., 2007) compared to those (n = 36) presenting
et al., 2007) Primary laminitis (Karikoski et al., 2011)
15 years
Laminitic horses signiﬁcantly older than hospital
controls (9 years; P < 0.001)
tandardbred, 86% pony, coldblood or warmblood
Ponies were signiﬁcantly overrepresented compared to
hospital controls (P = 0.002)
 with the risk of
riable analysis
al 1.37-18.19)
Not presentb
None
58%/34%
97%
86%
iagnosed on the basis of clinical signs, such as hyperaemic mucous membranes and
nia and toxic changes in neutrophils (Parsons et al., 2007).
2011).
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ponies presenting for lameness (Donaldson et al., 2004; Karikoski
et al., 2011).
The major endocrinopathic disorders resulting in laminitis are
EMS and/or PPID, the former characterised by obesity, insulin
resistance/dysregulation and laminitis (Frank et al., 2010; Frank
and Tadros, 2014). PPID is a disease of aged horses in which a loss
of dopaminergic inhibition of the pituitary pars intermedia
allows overproduction of pituitary hormones (including ACTH,
a-MSH, CLIP and b-endorphin) (McFarlane, 2011). The clinical
signs of PPID include hypertrichosis and abnormal hair shedding
patterns, muscle wastage, abnormal fat distribution, polyuria
and polydipsia, susceptibility to infection and infertility (McFar-
lane, 2011). PPID has also been suggested to cause both
hyperinsulinaemia and associated laminitis (Durham et al.,
2014), possibly in a subset of horses with PPID. Field based
epidemiological studies have shown that the prevalence of
hyperinsulinaemia (32%) and laminitis (13%) is greater in horses
with PPID than in age-matched controls (McGowan et al., 2013).
Higher values for the prevalence of laminitis are quoted in case
series (24–82%) that suffer bias from owner selection for
veterinary presentation (Schott, 2002). EMS, or at least hyper-
insulinaemia, is emerging as the predominant endocrine cause of
laminitis (Karikoski et al. 2011). Furthermore, in a recent
histological study of lamellar pathology, all horses and ponies
with PPID and lamellar pathology had fasting hyperinsulinaemia,
whereas PPID animals without lamellar pathology manifested
normal serum insulin concentrations (<20 mIU/L; Karikoski
et al., 2016).Fig. 2. Normal or ‘standard’ lamellae of the equine hoof, representing an integrated epide
and (b) 200 original magniﬁcation. The dermis arises axially from mesenchymal cells 
cells, which develop and invaginate to create primary and secondary lamellae. (c) In the 2
epidermal lamellae (SEL), which are acutely angled to the axis of the primary epidermal la
irregularity of the PEL/SEL interface. (d) Lamellae showing naturally occurring laminiti
adjacent to the hoof wall, at the top of image (2.5 original magniﬁcation).Paradigm shift 3: The pathology of laminitis: Endocrinopathic
versus SIRS-associated laminitis; different or a matter of
degree?
The ﬁnal paradigm shift involves changes in our understanding
of the pathology of laminitis, with the identiﬁcation of lamellar cell
stretch as an early and potentially crucial lesion (Karikoski et al.,
2014, 2015, 2016).
The availability of the hyperinsulinaemia model provided an
opportunity to compare hoof pathology to previous descriptions
based on SIRS-associated laminitis (Obel, 1948; Garner et al., 1975;
Roberts et al., 1980; Pollitt, 1996). While diseases associated with
SIRS are precipitous and frequently severe, endocrine disease is
typically chronic, with a potentially protracted subclinical phase.
However, exploration of the histology of the lamellar region in
either scenario revealed a relatively conservative spectrum of
lesions (Asplin et al., 2007; de Laat et al., 2011b, 2013a; Karikoski
et al., 2014, 2015, 2016), possibly reﬂecting a limited functional
plasticity for this highly specialised tissue or mechanistic
similarities in its injury. With the caveat that models of hyper-
insulinaemia manifest an abrupt rather than (more natural)
insidious onset of high insulin levels (in otherwise clinically
normal individuals), these models clearly demonstrate that
hyperinsulinaemia can cause laminitis, and indicates that lamellar
structures are an early target (6–48 h; de Laat et al., 2013a).
Comparable tissue from naturally occurring cases is unavailable,
which leaves experimental models as the only possible option with
which to comprehensively compare the early stages of endocri-
nopathic and SIRS-associated laminitis.rmal and dermal unit (epidermis overlying dermis) at (a) 2.5 original magniﬁcation
overlying the distal phalanx with the epidermis arising from overlying ectodermal
00 original magniﬁcation of laminitic secondary lamellae, the tips of the secondary
mellae (PEL), are lengthened, narrowed and tapered (rather than club-shaped), with
c changes axially, adjacent to the dermis, at the bottom of the image, to abaxially,
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The normal morphology of the lamellar region is variable in
terms of primary and secondary lamellar length, width, orientation
and type, which may reﬂect age, weight and the mechanical
environment (Kawasako et al., 2009; Karikoski et al., 2015).
Consequently, it can be challenging for the pathologist or
researcher to distinguish true pathological changes from normal
morphological variation. A classiﬁcation system for the morphol-
ogy of primary and secondary epidermal lamellae in ‘normal’
(35 Thoroughbred cadaver) horses described substantial histologi-
cal diversity, with hyperplastic secondary epidermal lamellae (SEL)
predominating in axial regions independent of clinical signs of
laminitis (Kawasako et al., 2009). This ﬁnding led to the suggestion
that attempts to diagnose or grade the severity of laminitis based
on histology would be ill-advised. However, since some of the
hooves studied were from horses euthanased for systemic
inﬂammatory disease, subclinical/early SIRS-associated laminitis
may have confounded these data. The same classiﬁcation system
was then applied to normal aged (12 years) and young (<12
years) horses and ponies that were stringently evaluated using
clinical inclusion and exclusion criteria inclusive of endocrine
status (Karikoski et al., 2015). Using this approach, lamellar
hyperplasia was not detected and the most common epidermal
lamellae subtypes were ‘standard’ (Fig. 2a and b). Primary
epidermal lamellae (PEL) were signiﬁcantly longer in horses than
ponies, and in older horses vs. their younger counterparts, both of
which were attributed to body weight/cumulative biomechanical
force (Karikoski et al., 2015).
Lamellar and cellular stretching is a key early lesion
Documented early histological changes in endocrinopathic and
SIRS-associated laminitis models have included loss of the
perpendicular orientation of SEL nuclei relative to their basement
membranes (BMs), nuclear rounding, a more centrally located
nucleus within the cytoplasm (vs. apical), with a more random
orientation and prominent nucleoli (Pollitt, 1996; Asplin et al.,
2010; de Laat et al., 2011b, 2013a). In both forms of laminitis, SEL
were observed to lengthen, narrow, develop tapered (vs. club-
shaped) tips and to become more acutely angled to the PEL axis,
with irregularity of the PEL/SEL interface. The PEL and SEL were
more closely apposed and frequently became difﬁcult to distin-
guish (Pollitt, 1996; Asplin et al., 2010; de Laat et al., 2011b, 2013a)
(Fig. 2c).
SEL elongation was thought to occur partly due to epidermal
cells sliding past each other (Pollitt, 2004) or because of increased
proliferative activity provoked by insulin (de Laat et al., 2013b).
Subsequently, lamellar/cellular elongation was found in fore and
hind feet of ponies with experimentally induced hyperinsulinae-
mic laminitis, in the absence of signiﬁcant lamellar disruption
(Karikoski et al., 2014). Stretching is now regarded as a key early
(and potentially primary) structural event, and was the earliest
noticeable histological change at the 6 h time point in Standard-
bred horses with induced hyperinsulinaemia (de Laat et al., 2013a).
This cellular stretching was accompanied and followed by
evidence of an accelerated cell death-proliferation cycle, although
the spatial/temporal relationships of these processes (cell death,
proliferation and stretching) remain obscure and vary between
models/studies (de Laat et al., 2013a; Karikoski et al., 2014).
Lamellar epithelial cell proliferation has not been evaluated in
SIRS-associated laminitis, but in hyperinsulinaemic horses it
occurs in acute experimental models and in chronic natural cases
of laminitis (de Laat et al., 2013a; Karikoski et al., 2014, 2015).
Apoptotic cells are a rarity in normal lamellar tissue and their
enrichment in hyperinsulinaemic models may be secondary tomechanical stress caused by lamellar epithelial cell stretching
(Asplin et al., 2010; Karikoski et al., 2014). Retrospective
examination of specimens from multiple hyperinsulinaemia
models suggests that it commences axially (adjacent to the distal
phalanx), spreading abaxially (toward the hoof wall) in a ‘wave’
that is followed by proliferation (Asplin et al., 2010; de Laat et al.,
2013a).
Is the sufﬁx ‘-itis’ applicable to the endocrinopathic disease?
Endocrinopathic laminitis, unlike SIRS-associated laminitis, is
associated with surprisingly minimal (histologically observable)
inﬂammation in both (chronic) naturally occurring and (acute)
experimentally induced laminitis, even where acute lamellar
tearing occurs (Asplin et al., 2010; de Laat et al., 2011b, 2013a;
Karikoski et al., 2014, 2015). In general, the extent and severity of
inﬂammation (indicated by neutrophils and activated macro-
phages) in both types of laminitis is less than that seen in many
other tissues (including skin) subject to similar levels of stress and
mechanical compromise (Morgan et al., 2003; Karikoski et al.,
2014). However, the more signiﬁcant leucocyte accumulation
noted in lamellar tissue in the developmental phase of carbohy-
drate overload-induced laminitis, which precedes and then
synchronously peaks with epithelial cell stress at the onset of
lameness (Black et al., 2006; de Laat et al., 2011b; Faleiros et al.,
2011), may indicate a key pathophysiological difference. The term
‘laminopathy’ might be a more appropriate morphological
descriptor for endocrinopathic laminitis.
Re-deﬁning the basement membrane focus
Prior to the development of the hyperinsulinaemic model, the
primary lesion of laminitis, and research focus, was generally
accepted to be BM injury (Pollitt, 1996; Eades, 2010). Diagrams
depicting a ‘degloving’ injury were based on observations of
lamellar explant separation under speciﬁc experimental condi-
tions (Pollitt, 1996, 2004), and early pathological changes in SIRS-
associated laminitis that implicated multiple BM targets (French
and Pollitt, 2004; Wang et al., 2012, 2013).
Interestingly, BM damage was not found in all carbohydrate
overload models, with one group noting that it remained intact and
attached during the acute phase (Morgan et al., 2003). In most
hyperinsulinaemia models, BM damage was minimal and pre-
dominantly localised to the most axial SEL only; neither all SEL, nor
all specimens were affected (Asplin et al., 2010; de Laat et al.,
2011b, 2013a). BM separation was absent ultra-structurally in
hyperinsulinaemic ponies (Nourian et al., 2009); there were
reduced numbers of hemi-desmosomes per unit length of BM, but
this was to a lesser degree than that measured in a carbohydrate
overload model (Nourian et al., 2007, 2009). However, in two
horses, more severe membrane separation occurred along the
length of the affected PEL following 48 h of hyperinsulinaemia,
with an observed increase in the severity of clinical signs (de Laat
et al., 2011b).
Matrix metalloproteinases (MMPs) are often proposed to be the
agents of BM breakdown, although we lack direct evidence for
their activities. Multiple MMPs are upregulated in SIRS-associated
laminitis with (some) signiﬁcant variation between individual
horses, but only pro-MMP-9 was increased in horses with induced
hyperinsulinaemia at 48 h, possibly due to small numbers of
inﬁltrating neutrophils (de Laat et al., 2011a). Furthermore, a
failure to demonstrate increased MMP-2 and MMP-9 (gelatinase)
activities in severe (carbohydrate-induced) laminitis was attribut-
ed to the activities of tissue inhibitors of MMP (Loftus et al., 2009).
Therefore, a primary role of BM pathology is debatable for both
endocrinopathic and SIRS-associated laminitis, although it
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following disease initiation.
The above ﬁndings do not clearly indicate if there is a genuine,
qualitative difference in histopathology between SIRS-associated
and endocrinopathic laminitis. While it is possible that differences
seen in structural/histological lesions in lamellae and their BM
could reﬂect the more precipitous nature of inﬂammatory disease,
the hyperinsulinaemia models also involve abrupt onset. An
analysis of the histological changes in strictly deﬁned, naturally
occurring cases of endocrinopathic disease was therefore consid-
ered to be essential in establishing whether these have any
relationship to lesions noted in the acute, experimental scenarios.
Histopathology of naturally occurring endocrinopathic laminitis and
the identiﬁcation of a preclinical stage
The histopathology of naturally occurring endocrinopathic
laminitis was described in 14 horses and ponies with reference to
25 age and breed-matched controls (Karikoski et al., 2015).
Microscopic lesions were largely localised abaxially (close to the
hoof wall) and included apoptosis, lamellar fusion, hyperplasia and
partial replacement with aberrant keratin containing nucleated
debris and proteinaceous lakes. The abaxial location of continuing
apoptosis correlated well with the axial-to-abaxial ‘wave’ of cell
death hypothesised from the developmental phases of experi-
mental models. These abaxial lesions were associated with
irregular margins between the stratum medium and the lamellar
tissue, and may indicate the following sequential events: (1) fusion
of SEL tips across the supporting dermal tissue, isolating rounded
areas of vascular dermal tissue; (2) continued centrifugal
keratinisation with production of increasing amounts of cap horn;Fig. 3. A range of abaxial lesions noted in horses with naturally occurring hyperinsulinaem
the following sequence of events: (a) fusion of tips of the secondary epidermal lamellae (S
of vascular dermal tissue that continue to keratinise peripherally (centrifugally) and prod
with complete isolation from the more axial (epidermal and dermal) tissue by keratin
degeneration of the blood vessel(s) and completion of keratinisation of the remaining (ce
Rows of these isolated and degenerate/keratinised circular foci were seen in the cap hdegeneration of blood vessel(s); and (3), inﬁll with keratin or
proteinaceous ﬂuid (Karikoski et al. 2015; Fig. 3).
In some horses with endocrinopathic laminitis, evidence of
acute tearing was superimposed on chronic pathology. Tearing in
chronic endocrinopathic laminitis was always abaxial and variably
involved BM separation, tearing of SEL and/or separation of the PEL
by ripping through the SEL bases (Karikoski et al., 2015). In acute
induction models associated with SIRS, tearing was mostly axial
and exclusively involved BM separation (Pollitt, 1996; de Laat et al.,
2011b). Axially in lamellar tissue from the endocrinopathic case
series, the lesions were less severe, but included tapering of SEL
and PEL ends (Fig. 2d). The largely abaxial localisation of chronic
lesions is incompletely understood, but may indicate a weakness
where SEL are anatomically proximal to each other, i.e. radial
arrangement around the abaxial end of primary dermal lamellae
(PDL), and experience potentially greater metabolic and/or
mechanical stress.
While the lesions seen in these naturally occurring cases are
consistent with progression of the lamellar stretching and
deformation noted acutely and possibly primarily in hyper-
insulinaemic models, they still do not clearly indicate if
endocrinopathic and SIRS-associated laminitis are fundamentally
different diseases. However, chronically developing endocrino-
pathic lesions were found to have a preclinical stage, implying a
‘window of opportunity’ for intervention (Karikoski et al., 2015).
This assertion is based on data showing that, while the type/
severity of lamellar lesions is not correlated with the reported
duration of pain (5–730 days, median 120 days), divergent hoof
rings were noted in all but one animal (13/14 horses); these rings
would have taken longer to develop (approximately 3 months;
Karikoski et al., 2015) than the known duration of laminitis (as aic laminitis (often within the same specimen) that were interpreted as representing
EL) across the primary dermal lamellae (PDL), resulting in isolation of rounded areas
uce increasing amounts of cap horn; (b) reduction in the area of this dermal ‘circle’,
, and keratinisation of most of the immediately surrounding epidermal tissue; (c)
ntral) epidermal cells; and (d) ﬁlling of the area with keratin or proteinaceous ﬂuid.
orn in many ﬁelds. Scale bar = 25 mm.
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associated with previous clinical episodes of laminitis or prolonged
chronic laminitis (Pollitt, 2004; Eustace, 2010). Management of
endocrine disease at this crucial stage might slow, prevent or even
reverse lamellar pathology, with the prevention of lamellar
stretching being an attractive therapeutic target in hyperinsuli-
naemia models.
Lamellar epithelial cell stretching: Possible mechanisms in the
hyperinsulinaemic horse
As above, histological ﬁndings in models of acute stages of
hyperinsulinaemia indicate stretching or elongation of lamellar
epithelial cells as a key early event. The (controversial) theory of
tensegrity usefully explains the forces that stabilise cells and how
these might be eroded in instances of mechanical failure. The
cytoskeleton is the arbiter of cell shape and mechanical properties,
with microtubules and actin microﬁlaments serving as compres-
sion-resisting elements (struts) and tensile components, respec-
tively; their interactions contribute to a pre-existing intracellular
tension termed ‘pre-stress’ (Ingber et al., 2014). Filamentous actin
can organise as ﬁlaments or bundles, with small variations in
ﬁlament or cross-link concentration, or external pre-stress, rapidly
altering mechanical strength of the cell (Gardel et al., 2004). The
major cytoskeletal proteins in equine lamellar tissue are keratins
(intermediate ﬁlaments, IFs) that contribute signiﬁcantly to the
mechanical properties of epithelial cells (Seltmann et al., 2013;
Carter et al., 2014). They are needed to anchor and exert strain on
the nucleus, while stabilising the cytoskeletal network as a whole
(Ingber, 2003; Maniotis et al., 1997). The cytoskeleton also
intersects with a highly elastic geodesic network of proteins
(actin, ankyrin and spectrin) located directly beneath the cell
membrane; the efﬁciency of this coupling depends on cell surface
adhesion complexes (i.e. integrins; Ingber, 2003). This theory
explains the transmission of local stresses over the cell’s entire
cytoskeletal architecture. At the higher level of cellular popula-
tions, there exists a complex relationship amongst cell shape, pre-
stress, connections with other cells, connections to the BM, and the
physical properties of that membrane (Ingber and Jamieson, 1985).
The BM is proposed to be a tension element of this higher order
tensegrity system, distributing physical forces in addition to
attaching epithelial and dermal components to each other (Ingber
and Jamieson, 1985). Any alteration to these components could
alter epithelial cell pre-stress, triggering events that may be
difﬁcult to determine using in vivo equine models. Rapid
elongation of the lamellar epithelial cells (within 6 h in the
hyperinsulinaemia models) implies plastic deformation of the
cytoskeleton, (Douglas et al., 1998; Davies et al., 2007). How or
when this might occur in association with more slowly developing
hyperinsulinaemia remains unknown. An alteration in keratin
expression has been demonstrated in basal and suprabasal cells in
the ﬁrst 48 h of laminitis, although at least one of the three horses
had SIRS-associated laminitis (Wattle, 2000).
In carbohydrate overload models, cytokeratin 14 immunoﬂuo-
rescence did not diminish, but became clustered around the
nucleus (French and Pollitt, 2004). It is also important to
appreciate that the cellular ability to tune pre-stress is essential
for homeostatic control, potentially explaining many of the
chronic disturbances that accompany the acute phase. At the
subcellular level, the nucleus is linked to surface adhesion
molecules via the IF network, with transmission of mechanical
forces and physical cues cable of inﬂuencing the transcriptome
(Maniotis et al., 1997; Wang et al., 2009). Collectively, these data
suggest that cellular stretch could direct early pharmacological
intervention strategies in horses showing preclinical divergent
hoof ring formation.Is stretching of lamellar epithelial cells due to direct actions of insulin?
Prolonged hyperinsulinaemia has not been found to upregulate
gene expression of (selected) markers of insulin signalling and
glucose transport in lamellar tissues (Campolo et al., 2016). In
studies using hoof lamellar explants, glucose uptake was
unaffected by insulin. Instead, mechanistic aspects of glucose
uptake, in conjunction with the expression of mRNAs for
GLUT1 and GLUT4, indicated the dominance of a GLUT1 (insu-
lin-independent) glucose transport system, rather than a glucose
deprivation model for laminitis (Asplin et al., 2011). In hyper-
insulinaemia models, GLUT1 was unaffected, although there were
increases in novel GLUTs (GLUTs 8 and 12; de Laat et al., 2015).
Insulin receptors are not expressed by lamellar epithelial cells, but
may be located in the vascular/stromal compartment, with gene
expression decreasing in hyperinsulinaemia models (Burns et al.,
2013; de Laat et al., 2013b). Taken together, these ﬁndings do not
indicate a direct cellular effect of insulin, but there are signiﬁcant
numbers of insulin-like growth factor (IGF)-1 (tyrosine kinase)
receptors (IGF-1Rs) in equine lamellar tissue (Kullmann et al.,
2016). While serum IGF-1 concentrations did not changesigniﬁ-
cantly over a 46 h period in hyperinsulinaemia models (de Laat
et al., 2013b), it is plausible that, at high concentrations, insulin
may bind to and activate IGF-1R, leading to receptor down-
regulation via negative feedback (de Laat et al., 2013b).
Supportive evidence is provided by a report of reduced levels
of lamellar IGF-R1 in obese horses, together with signiﬁcant
reductions in acute hyperinsulinaemia models (de Laat et al.,
2013b; Kullmann et al., 2016). In other cell types, IGF-1R has been
shown to interact in a dynamic fashion with integrins, intercel-
lular adhesion molecules, the cytoskeleton and intracellular
signalling cascades, including mitogen-activated protein (MAP)
kinases and phosphoinositide 3 (PI3) kinase. Reorganisation of
the cytoskeleton can occur in response to receptor activation,
largely studied in the context of cancer cell motility, migration
and epithelial to mesenchymal transition (EMT; Julien-Grille
et al., 2013).
The morphological alterations of lamellar epithelial cells
include some aspects of EMT, such as ﬂattening, spreading and
loss of cell-cell contacts. However, at least in the carbohydrate
overload model, there is no direct evidence of invasiveness/
motility, loss/internalisation of E-cadherin, gain of vimentin
expression (Wang et al., 2013) or propensity for malignant
transformation. While links exist between GLUT1 and the
cytoskeleton, these relate to subcellular targeting rather than
remodelling (Bunn et al., 1999). Determining whether there is a
direct hormonal inﬂuence on cellular cytoskeletal mechanics will
likely necessitate in vitro experimentation with superior lamellar
cell/explant culture models.
Is it the basement membrane after all?
As already mentioned, lamellar epithelial cell stretching may
reﬂect a hormone-induced change in the pre-stress state. However,
in cell culture, cells with fewer surface adhesions manifest reduced
stiffness and may rely more on internal microtubules to generate
pre-stress (Wang and Ingber, 1994). Conceivably, even minor
detachment associated with the subtle BM damage seen in
hyperinsulinaemia models could contribute to alterations in
epithelial cell tensegrity parameters. The distinction between
primary or secondary BM pathology may be very difﬁcult to make;
if lamellar epithelial cell elongation is primary, conceivably there
would be some change in the BM structure and/or elasticity to
accommodate this that would occur within a narrow time frame.
Such distinction within narrow time frames might be assisted by
detailed scrutiny of BM components, including proteolytic
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observational approaches.
While it is possible that endocrinopathic laminitis is a
(structurally) subtle lamellar BM disease, there is mixed evidence
for related inﬂammatory changes (as indicated in SIRS-associated
laminitis). While relationships between obesity-associated dis-
eases and pro-inﬂammatory cytokines are well established for
human patients (Dandona et al., 2004), the scenario in horses is
less clear. Pro-inﬂammatory effects, including increased levels of
tumour necrosis factor (TNF)-a, have been related to obesity
(Suagee et al., 2011) and have been noted in lamellar tissue of
horses with marked hyperinsulinaemia and laminitis (Obel grade
2; de Laat et al., 2014). However, increases in similar mediators
were not found in horses with moderate hyperinsulinaemia and
subclinical lamellar pathology in the hyperglycaemia model,
suggesting that they may not be involved in the earliest/key
stages of pathology. Additionally, ponies that were overfed
carbohydrate (provoking hyperinsulinaemia) failed to show
general up-regulation of lamellar pro-inﬂammatory cytokine gene
expression or leucocyte inﬁltration (Burns et al., 2015). However,
that study reported increased gene expression of cyclooxygenase-2
(COX-2); COX-2 signalling has been linked with IGF-1 stimulation
and EMT (Tian et al., 2012). In recent studies of carbohydrate
overload models, signiﬁcant increases in inﬂammatory gene
expression and transforming growth factor (TGF)-b1 protein were
found in micro-dissected lamellar basal epithelial cells (Leise et al.,
2015; Gutzmann et al., 2016). This type of tissue compartment-
speciﬁc analysis (proteomic or next generation sequencing [NGS])
is likely to be valuable in further exploration of the possible roles of
inﬂammation and BM damage in endocrinopathic laminitis.
Conclusions
The aim of this review was to highlight recent advances in our
understanding of the pathophysiology of endocrinopathic lami-
nitis, with suggestions as to future research avenues. Speciﬁcally,
laminitis is now considered to be a syndrome that most
commonly results from endocrine disease, with evidence of a
prolonged subclinical phase in at least some horses, as evidenced
by the development of divergent hoof rings. These hoof rings may
signify a window of opportunity for therapeutic intervention.
Histologically, structural BM lesions are subtle in comparison
with previous descriptions of rapid failure in SIRS-associated
laminitis, although other lesions are very similar, suggesting
convergent mechanisms or limited responses available to a highly
specialised tissue. Lamellar epithelial cell stretching is an early
and key event, suggesting cytoskeletal deformation and eroded
mechano-protection. Further mechanistic research is now war-
ranted to explore any causal relationship(s) between hyper-
insulinaemia and these cellular changes. Investigations should
focus on: (1) the earliest changes, possible invisible histologically
or ultra-structurally; (2) analyses of speciﬁc tissue compartments
using NGS and/or proteomics, in particular of basal lamellar
epithelial cells; and (3) investigation of possible links between
insulin, IGF-1R, cellular tensegrity, inﬂammatory mediators, and
BM composition/structure. Basic research at the cellular/molecu-
lar level is likely to be necessary to determine precisely how
hyperinsulinaemia drives the key and possibly preventable lesion
of lamellar stretching.
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